Alnylam Pharmaceuticals (1ALNY.MI) Q3 2025 Earnings

31JulConfirmed
Q1 2025
Q2 2025
Q3 2025
-0.79
-0.66
-0.52
-0.39

Details

Expected EPS
-0.4760716004
Actual EPS
-0.446556
Surprise EPS
0.03
Surprise Percent
+6.2%

Description

Alnylam Pharmaceuticals (1ALNY.MI) has reported earnings of -0.446556 per share for Q3 2025.

0 Comments

Share your thoughts